YGION Biomedical announces €15 Million Series A Financing from Austrian Private Trust to Develop Individualized Cancer Immunotherapies
Amount Raised
€15 Million
Round Type
Series A
ViennaBiotechnologyHealth CareTherapeuticsBiopharmaInvestors
Description
YGION Biomedical, a company dedicated to developing individualized neoantigen-based cancer vaccines, has announced the completion of a Series A financing round of €15 million from an Austrian private trust. The proceeds will be used to further develop YGION's unique YGNITETM technology platform and advance the lead program YG-01 into preclinical and clinical development.
Quick answer
YGION Biomedical raised €15 Million in a Series A round, dated May 21, 2024. Investors: Austrian Private Trust. YGION Biomedical is based in Vienna, Vienna, Austria.
- How much did YGION Biomedical raise?
- YGION Biomedical raised €15 Million in a Series A round on May 21, 2024.
- Who invested in YGION Biomedical?
- Austrian Private Trust is named as investors in this round.
- What does YGION Biomedical do?
- YGION Biomedical is an Austrian biotechnology company, dedicated to make individualized cancer immunotherapy a reality.
- Where is YGION Biomedical based and how big is it?
- YGION Biomedical is based in Vienna, Vienna, Austria.
- Who are the decision-makers at YGION Biomedical?
- Fundz holds 1 contact at YGION Biomedical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as YGION Biomedical that raised within 45 days of this round, from Fundz verified event records.
- Cartesian Therapeutics, Inc. raised $130M on July 2, 2024.
- DiaMedica Therapeutics raised $12M on June 28, 2024.
- CASI Pharmaceuticals raised $15M on June 26, 2024.
- CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
- DiaMedica Therapeutics raised $12M (Post-IPO Equity) on June 26, 2024.
- Summit Therapeutics raised $200M on June 3, 2024.
Who to call at YGION Biomedical, and when
A new round usually means YGION Biomedical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day YGION Biomedical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at YGION Biomedical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at YGION Biomedical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment YGION Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansYGION Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.